Primary and acquired resistance to antituberculous drugs in strains of Mycobacterium tuberculosis isolated in Rwanda;Résistance primaire et acquise aux antituberculeux des souches de Mycobacterium tuberculosis isolées au Rwanda

Medecine Tropicale

Volumn 67, Issue 2, 2007, Pages 149-153

  Umubyeyi Nyaruhirira, A N ^a,b   Rigouts, L ^c   Zissis, G ^c   Kamanzi, E ^d   Pauwels, P ^e   Gasana, M ^f   Vandebriel, G ^g   Struelens, M ^h   Portaels, F ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d Lab Natl de Ref   (Rwanda)

^e CTB   (Rwanda)

^f Programme National Intégré de Lutte Contre la Tuberculose et la Lèpre PNILT   (Rwanda)

^g Department of Medicine   (Rwanda)

^h ERASME HOSPITAL   (Belgium)

Author keywords

Antituberculosis drug resistance; HIV; Rwanda; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CULTURE MEDIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ADULT; CLINICAL TRIAL; FEMALE; MALE; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY; RETREATMENT; RWANDA;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RETREATMENT; RWANDA; TUBERCULOSIS, PULMONARY;

EID: 34748814913     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. WORLD HEALTH ORGANIZATION - Antituberculosis drug resistance in the world, third report. TheWHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1999-2002. WHO/HTM/ TB/2004.343. Geneva, 2004.
2. MINISTERE DE LA SANTE -Rapport annuel 2004 du Programme National Intégré de lutte contre la tuberculose et la lèpre au Rwanda. PNILT, 2005.
3. WORLD HEALTH ORGANIZATION. The WHO/IUATLD Global Project on anti-tuberculosis drugs resistance surveillance. WHO/TB/97.229.Geneva, 1997.
4. e Edition, Becton Dickinson, USA, 1998.
5. SIDDIQI SH. BACTEC 460 TB Systems. Product and procedure manual, 1996. Becton Dickinson and Company, 1996.
6. AZIZ M A, WRIGHT A, LASZLO A et Coll - Epidemiology of anti-tuberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006 ; 368 : 2142-54.
7. CARPELS G, FISSETTE K, LIMBANA V et Coll - Drug resistance tuberculosis in sub-Saharan Africa: an estimation of incidence and cost for the year 2000. Int J Tuberc Lung Dis 1995 ; 76 : 480-6.
8. GLYNN JR, JENKINS PA, FINE PE et Coll - Patterns of initial and acquired anti tuberculosis drug resistance in Karonga District, Malawi. Lancet 1995; 345 : 907-10.
9. CHANTEAU S, RASOLOFO V, RAMAROKOTO H et Coll - La résistance aux antituberculeux à Madagascar en 1994-1995. Int J Tuberc Lung Dis 1997; 1 : 405-10.
10. WILKINSON D, PILLARY M, DAVIES GR et Coll - Resistance to anti tuberculosis drugs in Rural South Africa: rates, patterns, risks, and transmission dynamics. Trans R Soc Trop Med Hyg 1996 ; 90 : 692-5.
11. GORDIN FM, NELSON ET, MATT's JP et Coll - The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Resp Crit Care Med 1996 ; 154 : 1478-83.
12. AUBRY P - La tuberculose à l'heure du sida, Actualités 2006. (http//medecinetropicale.free.fr/cours/tuberculose_sida.html).
13. RENOUX E, BARREH MATAN A, SEVRE JP et Coll - Tuberculose et infection VIH : expérience du programme national de lutte antituberculeuse de Djibouti: 1990-1996. Med Trop 2002 ; 62 : 171-6.
14. NELSON LJ, TALBOT EA, MWASEKAGA MJ et Coll - Antituberculosis drug surveillance and anonymous HIV surveillance among tuberculosis (TB) patients - Botswana. Int J Tuberc Lung Dis 2003 ; 7 : 208-9.
15. TREBUCQ A, ANAGONOU S, GNINAFON M et Coll - Prévalence de la résistance primaire et acquise de M. tuberculosis aux antituberculeux au Benin après 12 ans d'utilisation des traitements courts. Int J Tuberc Lung Dis 1999 ; 3 : 466-70.
16. UMUBYEYI AN, VANDEBRIEL G, GASANA M et Coll - Result of a National Survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis 2007; 11 : 189-95.